Analysis of target genes induced by IL-13 cytotoxin in human glioblastoma cells

Journal of Neuro-Oncology

Volumn 72, Issue 1, 2005, Pages 35-46

  Han, Jing ^a   Yang, Liming ^b   Puri, Raj K ^a,c  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

cDNA microarray; Gene expression profiles; IL 13cytotoxin; IL 13R 2 receptor

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 11; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 13 RECEPTOR ALPHA2; INTERLEUKIN 8; MESSENGER RNA; PSEUDOMONAS EXOTOXIN; ANTINEOPLASTIC AGENT; BACTERIAL TOXIN; CYTOTOXIN; EXOTOXIN; HYBRID PROTEIN; IL13 PE38QQR; IL13-PE38QQR; IL13RA1 PROTEIN, HUMAN; IMMUNOTOXIN; INTERLEUKIN 13 RECEPTOR ALPHA1; INTERLEUKIN RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TOXA PROTEIN, PSEUDOMONAS AERUGINOSA; TUMOR PROTEIN; VIRULENCE FACTOR;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL ADHESION; CELL CYCLE; CELL GROWTH; CELL MOTILITY; CELLULAR DISTRIBUTION; CLUSTER ANALYSIS; CONTROLLED STUDY; CYTOTOXICITY; DNA MICROARRAY; DNA REPAIR; DOSE RESPONSE; DRUG MECHANISM; GENE EXPRESSION PROFILING; GENE TARGETING; GLIOBLASTOMA; GLIOMA CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS INHIBITION; RANDOMIZATION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; BRAIN TUMOR; CELL DEATH; DRUG EFFECT; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ADP RIBOSE TRANSFERASES; ANTINEOPLASTIC AGENTS; APOPTOSIS; BACTERIAL TOXINS; BRAIN NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; CLUSTER ANALYSIS; CYTOTOXINS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXOTOXINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GLIOBLASTOMA; HUMANS; IMMUNOTOXINS; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; NEOPLASM PROTEINS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-13; RECOMBINANT FUSION PROTEINS; VIRULENCE FACTORS;

EID: 21244461152     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11060-004-3119-7     Document Type: Article

References (60)

1. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg LX, Edwards BK (eds) SEERS Cancer Statistics Review, 1973-1997, National cancer Institute. NIH Pub. No. 00-2789. Bethesda, MD 2000.
2. RK Puri P Leland RJ Kreitman I Pastan 1994 Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the toxic effects of IL-4 Pseudomonas exotoxin chimeric protein Int J Cancer 58 574-581
3. DW Laske RJ Youle EH Oldfield 1997 Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors Nature Med 3 1362-1368
4. CH Hao IF Parney WH Roa 2002 Cytokine and cytokine receptor mRNA expression in human glioblastoma: Evidence of Th1, Th2 and Th3 cytokine dysregulation Acta Neuropathol 103 171-178
5. NI Obiri W Debinski WJ Leonard RK Puri 1995 Receptor for interleukin 13: interaction with interleukin 4 by a mechanism that dose not involve the common γ chain shared by receptors for interleukin 2, 4, 7, 9, and 15 J Biol Chem 270 8797-8804
6. W Debinski NI Obiri SK Powers I Pastan RK Puri 1995 Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin Clin Cancer Res 1 1253-1258
7. SR Husain NI Obiri P Gill T Zhang I Pastan W Debinski RK Puri 1997 Receptor for interleukin 13 on AIDS-associated Kaposi's sarcoma cells serves as a new target for poten Pseudomonas exotoxin-based chimeric toxin protein Clin Cancer Res 3 151-156
8. BH Joshi GE Plautz RK Puri 2000 Interleukin-13 receptor a chain: A novel tumor-associated transmembrane protein in primary explants of human malignant gliomas Cancer Res 60 1168-1172
9. SR Husain BH Joshi RK Puri 2001 Interleukin-13 receptor as a unique target for anti-glioblastoma therapy Int J Cancer 92 168-175
10. DJ Hilton JG Zhang D Metcalf WS Alexander NA Nicola TA Willson 1996 Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor Proc Natl Acad Sci USA 93 497-501
11. MJ Aman N Tayebi NI Obiri RK Puri WS Modi WJ Leonard 1996 cDNA cloning and characterization of the human interleukin 13 receptor alpha chain J Biol Chem 271 29265-29270
12. T Murata NI Obiri RK Puri 1998 Structure of and signal transduction through interleukin-4 and interleukin-13 receptors Int J Mol Med 1 551-557
13. B Miloux P Laurent O Bonnin et al. 1997 Cloning of the human IL-13Rα1chain and reconstitution with the IL-4Rα of a functional IL-4/Il-13 receptor complex FEBS Lett 401 163-166
14. PL Orchansky R Kwan F Lee JW Schrader 1999 Characterization of the cytoplasmic domain of interleukin-13 receptor-α J Biol Chem 274 20818-20825
15. D Caput P Laurent M Kaghad 1996 Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor α chain. J Biol Chem 271 16921-16926
16. K Kawakami J Taguchi T Murata RK Puri 2001 The interleukin-13 receptor α2 chain: An essential component for binding and internalization but not for interleukin-13-induced signal transduction through STAT6 pathway Blood 97 2673-2679
17. K Kawakami F Takeshita RK Puri 2001 Identification of distinct roles for a dileucine and a tyrosine internalization motif in the interleukin (IL)-13 binding component IL-13 receptor alpha 2 chain J Biol Chem 276 25114-25120
18. W Debinski NI Obiri I Pastan RK Puri 1995 A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4 J Biol Chem 270 16775-16780
19. BH Joshi K Kawakami P Leland RK Puri 2002 Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: Differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxin Clin Cancer Res 8 1948-1956
20. RK Puri P Leland NI Obiri SR Husain RJ Kreitman GP Haas I Pastan W Debinski 1996 Targeting of IL-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated from of Pseudomonas exotoxin A (PE38QQR) Blood 87 4333-4339
21. SR Husain RK Puri 2000 Interleukin-13 fusion cytotoxin as a potent targeted agent for AIDS-Kaposi's sarcoma xenograft Blood 95 3506-3513
22. K Kawakami SR Husain M Kawakami RK Puri 2002 Improved anti-tumor activity and safety of interleukin-13 receptor targeted cytotoxin by systemic continuous administration in head and neck cancer xenograft model Mol Med 8 487-494
23. K Kawakami M Kawakami RK Puri 2002 Cytokine receptor as a sensitizer for targeted cancer therapy Anti-Cancer Drugs 13 693-699
24. M Kawakami K Kawakami RK Puri 2002 Intratumor administration of interleukin 13 receptor-targeted cytotoxin induces apoptotic cell death in human malignant glioma tumor xenografts Mol Cancer Therap 1 999-1007
25. K Kawakami BH Joshi RK Puri 2000 Sensitization of cancer cells to interleukin 13-Pseudomonas exotoxin-induced cell death by gene transfer of interleukin 13 receptor a chain Human Gene Therapy 11 1829-1835
26. Weingart J, Grossman SA, Bohan E, Fisher JD, Strauss L, Puri RK: Phase I/ II study of interstitial infusion of IL13-PE38QQR cytotoxin in recurrent malignant glioma. First Quadrennial meeting - World Federation of Neuro-Oncology, November 15-17, 2001, Washington, DC.
27. J Weingart LC Strauss SA Grossman J Markett S Tatter JD Fisher CK Fleming RK Puri 2002 Phase I/II study: Intra-tumoral infusion of IL13-PE38QQR cytotoxin for recurrent supratentorial malignant glioma. Neoro-oncol 4 379
28. Prados MD, Lang FF, Strauss L, Fleming C, Alalpe K, Kunwar S, Yung WKA, Chang S, Husain SR, Gutin PH, Raizer J, Piepmeier JM, Berger M, McDermott M, Puri RK: Intratumoral and intracerebral microinfusion of IL13-PE38QQR cytotoxin: Phase I/II study of pre- and post-resection infusions in recurrent resectable malignant glioma. Proc. Am. Soc. Clin. Oncol. 21, 69 (Abstract 2087), 2002.
29. Lang F, Kunwar S, Strauss L, Gutin P, Piepmeier J, McDermott M, Fleming C, Sherman J, Raizer J, Alalpe K, Yung WKA, Husain SR, Chang S, Berger M, Prados M, Puri RK: A clinical study of convection-enhanced delivery of IL13-PE38QQR cytotoxin Pre- and post- resection of recurrent GBM. American Society of Neuro-Oncologists Chicago, April 2002.
30. Prados MD, Lang FF, Sherman JW, Strauss LC, Fleming CK, Alalpe K, Kunwar S, Yung WKA, Chang SM, Husain SR, Gutin PH, Raizer J, Piepmeier JM, Berger M, McDermott M, Puri RK: Convection-enhanced delivery (CED) by positive pressure infusion for intra- tumoral and peri-tumoral administration of IL13-PE38QQR a recombinant tumor-targeted cytotoxin in recurrent malignant glioma. Neuro-Oncol 4: S78, 2002(B).
31. M Schena D Shalon RW Davis PO Brown 1995 Quantitative monitoring of gene expression patterns with a complementary DNA microarray Science 270 467-470 1:CAS:528:DyaK2MXovVersLk%3D 7569999
32. DDL Bowtell 1999 Options available- from start to finish-for obtaining expression data by microarray Nat Genet 21 25-32
33. JR Pollack CM Perou AA Alizadeh MB Eisen A Pergamenschikov CF Williams SS Jeffrey D Botstein PO Brown 1999 Genome-wide analysis of DNA copy-number changes using cDNA microarrays Nat Genet 23 41-46
34. HC King AA Sinha 2001 Gene expression profile analysis by DNA microarray JAMA 286 2280-2288
35. DD Shoemaker EE Schadt CD Armour YD He P Garrett-Engele PD McDonagh PM Loerch A Leonardson PY Lum G Cavet LF Wu SJ Altschuler S Edwards J King JS Tsang G Schimmack JM Schelter J Koch M Ziman MJ Marton B Li P Cundiff T Ward J Castlw M Krolewski MR Meyer M Mao J Burchard MJ Kidd H Dal JW Pillips PS Linsley R Stoughton S Scherer MS Bouguski 2001 Experimental annotation of the human genome using microarray technology Nature 409 922-927
36. LJ Veer H Dai MJ Vijver YD He AAM Hart M Mao HL Peterse KV Kooy MJ Marton AT Witteveen GJ Schreiber RM kerkhoven C Roberts PS Linsley R Bernards SH Friend 2002 Gene expression profiling predicts clinical outcome of breast cancer Nature 415 530-536 10.1038/415530a 11823860
37. A Brazma P Higamp J Quackenbush G Sherlock P Spellman C Stoeckert J Aach W Anssorge CA Ball HC Causton T Gaasterland P Glenisson FCP Holstege IF Kim V Markowitz JC Matese H Parkinson A Robinson U Sarkans S Schulze-Kremer J Stewart R Taylor J Vilo M Vingron 2001 Minimum information about a microarray experiment (MIAME)-toward standards for microarray data Nat Genet 29 365-371 10.1038/ng1201-365
38. A Calvo N Xiao J Kang CJ Best I Leiva MR Emmert-Buck C Jorcyk JE Green 2002 Alterations in gene expression profiles during prostate cancer progression: Functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors Cancer Res 62 5325-5335
39. JI Risinger GL Maxwell GV Chandramouli A Jazaeri O Aprelikova T Patterson A Berchuck JC Barrett 2003 Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer Cancer Res 63 6-11
40. AD Irvine AM Christiano 2001 Hair on a gene string: Recent advances in understanding the molecular genetics of hair loss Clin Exp Dermatol 26 59-71
41. I Sargiannidou J Zhou GP Tuszynski 2001 The role of thrombospondin-1 in tumor progression Exp Biol Med 226 726-733
42. WR Montfort A Weichsel 1997 Thymidylate synthase: Structure, inhibition, and strained conformations during catalysis Pharmacol Ther 76 29-43
43. AM Babic ML Kireeva TV Kolesnikova LF Lau 1998 CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth PNAS USA 95 6355-6360
44. M Wagner JP Klussmann R Fangmann R Linder ME Elewa S Eidt VM Rose M Jungehulsing HJ Schulze 2001 Cyclin-dependent kinase-inhibitor 1 (CDKN1A) in the squamous epithelium of the oropharynx: Possible implications of molecular biology and compartmentation Anticancer Res 21 1A 333-334
45. R Zhou D Diehl A Hoeflich H Lahm 2003 IGF-binding protein-4: Biochemical characteristics and functional consequences J Endocrinol 178 177-193 1:CAS:528:DC%2BD3sXmvFGns7s%3D 12904166
46. PC Heinrich I Behrmann S Haan HM Hermanns G Muller-Newen F Schaper 2003 Principles of interleukin (IL)-6-type cytokine signalling and its regulation Biochem J 374 Pt 1 1-20
47. W Zhang I Bae K Krishnaraju N Azam W Fan K Smith B Hoffman DA Leibermann 1999 CR6: A third member in the MyD118 and Gadd 45 family which functions in negative growth control Oncogene 18 749-757
48. ML Smith JM Ford MC Hollander RA Bortnick SA Amundson YR Seo CX Deng PC Hanawalt AJ Fornace 2000 p53-mediated DNA repair responses to UV radiation: Studies of mouse cells lacking p53, p21, and /or gadd45 genes Mol Cell Biol 20 3705-3714
49. DP Harkin JM Bean D Miklos YH Song VB Truong C Englert FC Christians LW Ellison S Maheswaran JD Oliner DA Haber 1999 Induction of GADD45 and JNK/ SARK-dependent apoptosis following inducible expression of BRC1 Cell 97 575-586
50. DA Liebermann B Hoffman 2002 Myeloid differentiation (MyD)/growth arrest DNA damage (GADD) genes in tumor suppression, immunity and inflammation Leukemia 16 527-541
51. C Aschele S Lonardi S Monfardini 2002 Thymidylate synthase expression as a predictor of clinical response to fluoropyrimidine-base chemotherapy in advanced colorectal cancer Cancer Treat Rev 28 27-47 10.1053/ ctrv.2002.0253 1:CAS:528:DC%2BD38XlsVeisbk%3D 12027413
52. H Chen ME Herndon J Lawler 2000 The cell biology of thrombospondin-1 Matrix Biol 19 597-614
53. K Blease C Jakubzick JM Schuh BH Joshi RK Puri CM Hogaboam 2001 IL-13 fusion cytotoxin ameliorates chronic fungal-induced allergic airway disease in mice J Immunol 167 6583-6592
54. T Murata PD Noguchi RK Puri 1996 Il-13 induces phosphorylation and activation of JAK2 janus kinase in human colon carcinoma cell line J Immunol 156 2972-2978
55. DL Krebs DJ Hilton 2000 SOCS: Physiological suppressors of cytokine signaling. J Cell Sci 113 Pt 16 2813-2819 1:CAS:528:DC%2BD3cXmslygtrs%3D 10910765
56. M Weaver DW Laske 2003 Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas J Neuro Oncol 65 3-13
57. LL Muldoon EA Neuwelt 2003 BR96-DOX immunoconjugate targeting of chemotherapy in brain tumor models J Neuro Oncol 65 49-62
58. M Kawakami K Kawakami RK Puri 2003 Interleukin-4 Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy J Neuro Oncol 65 15-25
59. N Guo VS Zabrenetzky L Chandrasekaran JM Sipes J Lawler HC Krutzsch DD Roberts 1998 Differential roles of protein kinase C and pertussis toxin-sensitive G-binding proteins in modulation of melanoma cell proliferation and motility by thrombospondin-1 Cancer Res 58 3154-3162
60. OV Volpert J Lawler NP Bouck 1998 A human fibrosacoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1 Proc Natl Acad Sci USA 95 6343-6348